Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Oral formulation of Triapine demonstrates oral bioavailability

Dec. 18, 2002

Antitumor compounds discovered at Zenyaku Kogyo

Dec. 18, 2002

Small-molecule XIAP antagonist identified by La Jolla-based team

Dec. 17, 2002

Spectrum expands Neoquin study in superficial bladder cancer

Dec. 17, 2002

Medarex acquires anti-PSMA antibody rights from Northwest Biotherapeutics

Dec. 17, 2002

Lilly seeks expanded indication for Gemzar in Europe

Dec. 17, 2002

Kirin Brewery designs new urea-based antitumor agents

Dec. 17, 2002

Novartis patent covers new VEGFR inhibitors for cancer, pain, etc.

Dec. 17, 2002

New data on liposomal vincristine combined with rituximab in leukemia

Dec. 17, 2002

U. of Padova researchers design novel antitumor aloe-emodin derivatives

Dec. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.